BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Natural Gas Services Group
NGS
$335M
| $242K | ﹤0.01% |
9,040
+393
| +5% | +$10.5K |
|
2777
Federal Agricultural Mortgage
AGM
$2.15B
| $242K | ﹤0.01% |
1,230
-4,820
| -80% | -$949K |
|
2778
Global X Silver Miners ETF NEW
SIL
$3.19B
| $242K | ﹤0.01% |
7,614
+1,413
| +23% | +$44.9K |
|
2779
Nathan's Famous
NATH
$441M
| $241K | ﹤0.01% |
3,061
-472
| -13% | -$37.1K |
|
2780
Hertz
HTZ
$1.99B
| $240K | ﹤0.01% |
+65,581
| New | +$240K |
|
|
ALEX
2781
Alexander & Baldwin
ALEX
$1.34B
| $240K | ﹤0.01% |
13,509
-3,252
| -19% | -$57.7K |
|
2782
ANI Pharmaceuticals
ANIP
$2.12B
| $240K | ﹤0.01% |
4,335
-3,595
| -45% | -$199K |
|
2783
Applied Optoelectronics
AAOI
$1.69B
| $238K | ﹤0.01% |
6,458
-1,364
| -17% | -$50.3K |
|
2784
Anika Therapeutics
ANIK
$125M
| $238K | ﹤0.01% |
14,448
+11,607
| +409% | +$191K |
|
|
SOHU
2785
Sohu.com
SOHU
$480M
| $238K | ﹤0.01% |
18,021
+12,502
| +227% | +$165K |
|
2786
Edgewell Personal Care
EPC
$1.01B
| $237K | ﹤0.01% |
7,068
-17,870
| -72% | -$600K |
|
2787
Beam Therapeutics
BEAM
$2.08B
| $237K | ﹤0.01% |
+9,552
| New | +$237K |
|
|
LOMA
2788
Loma Negra
LOMA
$888M
| $236K | ﹤0.01% |
19,807
+7,232
| +58% | +$86.4K |
|
2789
FB Financial Corp
FBK
$2.86B
| $236K | ﹤0.01% |
4,588
-5,172
| -53% | -$266K |
|
2790
Akero Therapeutics
AKRO
$3.48B
| $236K | ﹤0.01% |
8,482
-12,220
| -59% | -$340K |
|
|
SLRN
2791
DELISTED
ACELYRIN
SLRN
| $236K | ﹤0.01% |
+75,114
| New | +$236K |
|
|
JKS
2792
JinkoSolar
JKS
$1.3B
| $236K | ﹤0.01% |
9,471
-61,257
| -87% | -$1.53M |
|
2793
FS Bancorp
FSBW
$315M
| $235K | ﹤0.01% |
5,728
+1,094
| +24% | +$44.9K |
|
2794
Adeia
ADEA
$1.71B
| $234K | ﹤0.01% |
+16,758
| New | +$234K |
|
2795
Alignment Healthcare
ALHC
$3.18B
| $234K | ﹤0.01% |
+20,821
| New | +$234K |
|
2796
Esquire Financial Holdings
ESQ
$828M
| $234K | ﹤0.01% |
2,944
-3,284
| -53% | -$261K |
|
2797
Redwire
RDW
$1.25B
| $234K | ﹤0.01% |
+14,219
| New | +$234K |
|
2798
Recursion Pharmaceuticals
RXRX
$2.11B
| $233K | ﹤0.01% |
+34,504
| New | +$233K |
|
2799
GrafTech
EAF
$261M
| $232K | ﹤0.01% |
13,395
+612
| +5% | +$10.6K |
|
2800
Pilgrim's Pride
PPC
$10.4B
| $231K | ﹤0.01% |
5,100
-153,726
| -97% | -$6.98M |
|